A hypnic hypothesis of alzheimer's disease

Neurodegenerative Diseases

Volumn 12, Issue 4, 2013, Pages 165-176

  Clark, Camilla N ^a   Warren, Jason D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Default mode network; Neurodegeneration; Sleep

Indexed keywords

NEUROTRANSMITTER;

ALZHEIMER DISEASE; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CELLULAR PARAMETERS; HUMAN; HYPOTHESIS; MOLECULAR BIOLOGY; NERVE DEGENERATION; NEUROANATOMY; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE; SUBCORTEX; SYNAPTIC TRANSMISSION; NERVE CELL NETWORK; NEUROPATHOLOGY;

ALZHEIMER DISEASE; BRAIN STEM; HUMANS; NEURAL PATHWAYS; SLEEP DISORDERS, CIRCADIAN RHYTHM; SYNAPTIC TRANSMISSION;

EID: 84887103122     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000350060     Document Type: Review

References (102)

1. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
2. Braak H, Del Tredici K: The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 2011; 121: 171-181.
3. Fontejin HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ, Scahill RI, Tabrizi SJ, Ourselin S, Fox NC, Alexander DC: An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. Neuroimage 2012; 60: 1880-1889.
4. Schliebs R, Arendt T: The cholinergic system in aging and neuronal degeneration. Behav Brain Res 2011; 221: 555-563.
5. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH: Toward defining preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 280-292.
6. Buckner RL, Snyder AZ, Shannon BJ, La Rossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA: Molecular, structural and functional characterisation of Alzheimer's disease: evidence for a relationship between default activity, amyloid and memory. J Neurosci 2005; 25: 7709-7717. (Pubitemid 41208641)
7. Buckner RL, Andrews-Hanna JR, Schacter DL: The brain's default network: anatomy, function, and relevance to disease: Ann NY Acad Sci 2008; 1124: 1-38. (Pubitemid 351506788)
8. Pievani M, de Haan W, Wu T, Seeley WW, Frisoni GB: Functional network disruption in the degenerative dementias. Lancet Neurol 2011; 10: 829-843.
9. Warren JD, Rohrer JD, Hardy J: Disintegrating brain networks from syndromes to molecular nexopathies. Neuron 2012; 73: 1060-1062.
10. Garden GA, La Spada AR: Intercellular (mis) communication in neurodegenerative disease. Neuron 2012; 73: 886-901.
11. Crews L, Masliah E: Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet 2010; 19:R12-R20.
12. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL: A default mode of brain function. Proc Natl Acad Sci USA 2001; 98: 676-682. (Pubitemid 32105102)
13. Cavanna AE, Trimble MR: The precuneus: a review of its functional anatomy and behavioural correlates. Brain 2006; 129: 564-583. (Pubitemid 43278220)
14. De Calignon A, Polydoro M, Suárez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, Spires-Jones TL, Hyman BT: Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012; 73: 685-697.
15. Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K: Trans-synaptic spread of tau pathology in vivo. PLoS One 2012; 7:e31302.
16. Harris JA, Devidze N, Verret L, Ho K, Halabisky B, Thwin MT, Kim D, Hamto P, Lo I, Yu GQ, Palop JJ, Masliah E, Mucke L: Transsynaptic progression of amyloid-?-induced neuronal dysfunction within the entorhinalhippocampal network. Neuron 2010; 68: 428-441.
17. Nizzari M, Thellung S, Corsaro A, Villa V, Pagano A, Porcile C, Russo C, Florio T: Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling. J Toxicol 2012; 2012: 187297.
18. Bachmann V, Klein C, Bodenmann S, Schäfer N, Berger W, Brugger P, Landolt HP: The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency and state specificity. Sleep 2012; 35: 335-344.
19. Hanlon EC, Vyazovskiy VV, Faraguna U, Tononi G, Cirelli C: Synaptic potentiation and sleep need: clues from molecular and electrophysiological studies. Curr Top Med Chem 2011; 11: 2472-2482.
20. Vyazovskiy VV, Cirelli C, Pfister-Genskow M, Faraguna U, Tononi G: Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci 2008; 11: 200-208. (Pubitemid 351170495)
21. Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, Lee JM, Holtzman DM: Neuronal activity regulates the regional vulnerability to amyloid-? deposition. Nat Neurosci 2011; 14: 750-756.
22. Cirelli C: Cellular consequences of sleep deprivation in the brain. Sleep Med Rev 2006; 10: 307-321. (Pubitemid 44307714)
23. Feng Z, Chang Y, Cheng Y, Zhang BL, Qu ZW, Qin C, Zhang JT: Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease. J Pineal Res 2004; 37: 129-136. (Pubitemid 39120217)
24. Huang Y, Potter R, Sigurdson W, Santacruz A, Shih S, Ju YE, Kasten T, Morris JC, Mintun M, Duntley S, Bateman RJ: Effects of age and amyloid deposition on A? dynamics in the human central nervous system. Arch Neurol 2012; 69: 51-58.
25. Huitrón-Reséndiz S, Sánchez-Alavez M, Gallegos R, Berg G, Crawford E, Giacchino JL, Games D, Henriksen SJ, Criado JR: Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res 2002; 928: 126-137. (Pubitemid 34159059)
26. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM: Amyloid-? dynamics are regulated by orexin and the sleep-wake cycle. Science 2009; 326: 1005-1007.
27. Kondratova AA, Kondratov RV: The circadian clock and pathology of the ageing brain. Nat Rev Neurosci 2012; 13: 325-335.
28. Matsubara E, Bryant-Thomas T, Pacheco Quinto J, Henry TL, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan YJ, Smith MA, Perry G, Shoji M, Abe K, Leone A, Grundke-Ikbal I, Wilson GL, Ghiso J, Williams C, Refolo LM, Pappolla MA, Chain DG, Neria E: Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem 2003; 85: 1101-1108. (Pubitemid 36613258)
29. Montgomery SM, Sirota A, Buzsáki G: Theta and gamma coordination of hippocampal networks during waking and rapid eye movement sleep. J Neurosci 2008; 28: 6731-6741.
30. Naidoo N, Ferber M, Master M, Zhu Y, Pack AI: Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. J Neurosci 2008; 28: 6539-6548.
31. Poeggeler B, Miravalle L, Zagorski MG, Wisniewski T, Chyan YJ, Zhang Y, Shao H, Bryant-Thomas T, Vidal R, Frangione B, Ghiso J, Pappolla MA: Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid A? peptide. Biochemistry 2001; 40: 14995-15001. (Pubitemid 33136121)
32. Rodríguez-Vázquez J, Camacho-Arroyo I, Velázquez- Moctezuma J: Differential impact of REM sleep deprivation on cytoskeletal proteins of brain regions involved in sleep regulation. Neuropsychobiology 2012; 65: 161-167.
33. Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, Holtzman DM: Disruption of the sleep-wake cycle and diurnal fluctuation of ?-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med 2012; 4: 150ra122.
34. He B, Peng H, Zhao Y, Zhou H, Zhao Z: Modafinil treatment prevents REM sleep deprivation-induced brain function impairment by increasing MMP-9 expression. Brain Res 2011; 1426: 38-42.
35. Bachman D, Rabins P: 'Sundowning' and other temporally associated agitation states in dementia patients. Annu Rev Med 2006; 57: 499-511. (Pubitemid 43262004)
36. Bombois S, Derambure P, Pasquier F, Monaca C: Sleep disorders in aging and dementia. J Nutr Health Aging 2010; 14: 212-217.
37. Bonanni E, Maestri M, Tognoni G, Fabbrini M, Nucciarone B, Manca ML, Gori S, Iudice A, Murri L: Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment. J Sleep Res 2005; 14: 311-317. (Pubitemid 41291317)
38. Furio AM, Brusco LI, Cardinali DP: Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study. J Pineal Res 2007; 43: 404-409. (Pubitemid 47512272)
39. Moe KE, Vitiello MV, Larsen LH, Prinz PN: Symposium: cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J Sleep Res 1995; 4: 15-20.
40. Vilalta-Franch J, López-Pousa S, Llinàs-Reglà J, Calvó-Perxas L, Merino-Aguado J, Garre-Olmo J: Depression subtypes and 5-year risk of dementia and Alzheimer disease in patients aged 70 years. Int J Geriatr Psychiatry 2013; 28: 341-350.
41. Wdos MS, Poyares DR, Guilleminault C, Ramos LR, Bertolucci PH, Tufik S: The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study. Sleep 2006; 29: 199-205. (Pubitemid 44019974)
42. Wulff K, Gatti S, Wettstein JG, Foster RG: Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci 2010; 11: 589-599.
43. De Haan W, Mott K, van Straaten EC, Scheltens P, Stam CJ: Activity-dependent degeneration explains hub vulnerability in Alzheimer's disease. PLoS Comput Biol 2012; 8:e1002582.
44. Ranjan A, Biswas S, Mallick BN: Cytomorphometric changes in the dorsal raphe neurons after rapid eye movement sleep deprivation are mediated by noradrenalin in rats. Behav Brain Funct 2010; 6: 62.
45. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM: Synaptic activity regulates interstitial fluid amyloid-? levels in vivo. Neuron 2005; 48: 913-922. (Pubitemid 41814696)
46. Hobson JA, Friston KJ: Waking and dreaming consciousness: neurobiological and functional considerations. Prog Neurobiol 2012; 98: 82-98.
47. Born J, Feld GB: Sleep to upscale, sleep to downscale: balancing homeostasis and plasticity. Neuron 2012; 75: 933-935.
48. Shaffery JP, Lopez J, Roffwarg HP: Brain-derived neurotrophic factor (BDNF) reverses the effects of rapid eye movement sleep deprivation (REMSD) on developmentally regulated, long-term potentiation (LTP) in visual cortex slices. Neurosci Lett 2012; 153: 84-88.
49. Vyazovskiy VV, Cirelli C, Pfister-Genskow M, Faraguna U, Tononi G: Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci 2008; 11: 200-208. (Pubitemid 351170495)
50. Zhou JN, Liu RY, Kamphorst W, Hofman MA, Swaab DF: Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res 2003; 35: 125-130. (Pubitemid 36960352)
51. Jedidi Z, Rikir E, Muto V, Mascetti L, Kussé C, Foret A, Shaffii-Le Bourdiec A, Vandewalle G, Maquet P: Functional neuroimaging of the reciprocal influences between sleep and wakefulness. Pflugers Arch 2012; 463: 103-109.
52. Grosmark AD, Mizuseki K, Pastalkova E, Diba K, Buzsáki G: REM sleep reorganizes hippocampal excitability. Neuron 2012; 75: 1001-1007.
53. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC: Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 2002; 99: 4703-4707. (Pubitemid 34286048)
54. Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, Lee JM, Holtzman DM: Neuronal activity regulates the regional vulnerability to amyloid-? deposition. Nat Neurosci 2011; 14: 750-756.
55. Avidan AY: Sleep in the geriatric patient population. Semin Neurol 2005; 25: 52-63. (Pubitemid 40471626)
56. Benarroch EE: Suprachiasmatic nucleus and melatonin: reciprocal interactions and clinical correlations. Neurology 2008; 71: 594-598.
57. Bondareff W, Mountjoy CQ, Roth M: Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 1982; 32: 164-168. (Pubitemid 12223999)
58. Craig D, Hart DJ, Passmore AP: Genetically increased risk of sleep disruption in Alzheimer's disease. Sleep 2006; 29: 1003-1007. (Pubitemid 44257376)
59. Dang-Vu TT, Schabus M, Desseilles M, Sterpenich V, Bonjean M, Maquet P: Functional neuroimaging insights into the physiology of human sleep. Sleep 2010; 33: 1589-1603.
60. Domhoff WG: The neural substrate for dreaming: is it a subsystem of the default network? Conscious Cogn 2011; 20: 1163-1174.
61. Guarnieri B, Adorni F, Musicco M, Appollonio I, Bonanni E, Caffarra P, Caltagirone C, Cerroni G, Concari L, Cosentino FI, Ferrara S, Fermi S, Ferri R, Gelosa G, Lombardi G, Mazzei D, Mearelli S, Morrone E, Murri L, Nobili FM, Passero S, Perri R, Rocchi R, Sucapane P, Tognoni G, Zabberoni S, Sorbi S: Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross sectional study on 431 patients. Dement Geriatr Cogn Disord 2012; 33: 50-58.
62. Gabelle A, Dauvilliers Y: Editorial: sleep and dementia. J Nutr Health Aging 2010; 14: 201-202.
63. George O, Vallée M, Le Moal M, Mayo W: Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age-related changes. Psychopharmacology (Berl) 2006; 186: 402-413. (Pubitemid 43800841)
64. Hobson JA, Pace-Schott EF: The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci 2002; 3: 679-693. (Pubitemid 135706674)
65. Hobson JA: REM sleep and dreaming: towards a theory of protoconsciousness. Nat Rev Neurosci 2009; 10: 803-813.
66. Rossor MN: Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. Br Med J (Clin Res Ed) 1981; 283: 1588-1590. (Pubitemid 12239417)
67. Yesavage JA, Friedman L, Kraemer H, Tinklenberg JR, Salehi A, Noda A, Taylor JL, O'Hara R, Murphy G: Sleep/wake disruption in Alzheimer's disease: APOE4 status and longitudinal course. J Geriatr Psychiatry Neurol 2004; 17: 20-24. (Pubitemid 38294537)
68. España RA, Scammell TE: Sleep neurobiology from a clinical perspective. Sleep 2011; 34: 845-858.
69. Pace-Schott EF, Spencer RM: Age-related changes in the cognitive function of sleep. Prog Brain Res 2011; 191: 75-89.
70. McCurry SM, Reynolds CF, Ancoli-Israel S, Teri L, Vitiello MV: Treatment of sleep disturbance in Alzheimer's disease. Sleep Med Rev 2000; 4: 603-628. (Pubitemid 32104354)
71. Singer M, Romero B, Koenig E, Förstl H, Brunner H: Nightmares in patients with Alzheimer's disease caused by donepezil. Therapeutic effect depends on the time of intake (in German). Nervenarzt 2005; 76: 1127-1129.
72. Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R, Wherrett J, Naglie G, Hamani C, Smith GS, Lozano AM: A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol 2010; 68: 521-534.
73. Mesulam MM: Structure and function of cholinergic pathways in the cerebral cortex, limbic system, basal ganglia, and thalamus of the human brain; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, pp 135-146.
74. Mascetti L, Foret A, Bourdiec AS, Muto V, Kussé C, Jaspar M, Matarazzo L, Dang-Vu T, Schabus M, Maquet P: Spontaneous neural activity during human non-rapid eye movement sleep. Prog Brain Res 2011; 193: 111-118.
75. Wyatt JK, Ritz-De Cecco A, Czeisler CA, and Dijk DJ: Circadian temperature and melatonin rhythms, sleep, and neurobehavioral function in humans living on a 20-hour day. Am J Physiol 1999; 277:R1152-R1163. (Pubitemid 29525972)
76. Maquet P: Understanding non rapid eye movement sleep through neuroimaging. World J Biol Psychiatry 2010; 11: 9-15.
77. Desseilles M, Dang-Vu TT, Sterpenich V, Schwartz S: Cognitive and emotional processes during dreaming: a neuroimaging view. Conscious Cogn 2011; 20: 998-1008.
78. Spreng RN, Mar RA, Kim AS: The common neural basis of autobiographical memory, prospection, navigation, theory of mind, and the default mode: a quantitative meta-analysis. J Cogn Neurosci 2009; 21: 489-510.
79. Koike T, Kan S, Misaki M, Miyauchi S: Connectivity pattern changes in default-mode network with deep non-REM and REM sleep. Neuroimage 2011; 69: 322-330.
80. Donlea JM, Ramanan N, Shaw PJ: Use-dependent plasticity in clock neurons regulates sleep need in Drosophila. Science 2009; 324: 105-108.
81. Gilestro GF, Tononi G, Cirelli C: Widespread changes in synaptic markers as a function of sleep and wakefulness in Drosophila. Science 2009; 324: 109-112.
82. Debeir T, Saragovi HU, Cuello AC: A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat. Proc Natl Acad Sci USA 1999; 96: 4067-4072. (Pubitemid 29169037)
83. Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A: Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci USA 2000; 97: 6826-6831. (Pubitemid 30412799)
84. Daulatzai MA: Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia-a novel hypothesis. Neurochem Res 2012; 37: 846-868.
85. Jackowska M, Hamer M, Carvalho LA, Erusalimsky JD, Butcher L, Steptoe A: Short sleep duration is associated with shorter telomere length in healthy men: findings from the Whitehall II Cohort Study. PLoS One 2012; 7:e47292.
86. Oliveira JR, Nishimura AL, Lemos RR, Zatz M: The genetics of Alzheimer's disease in Brazil: 10 years of analysis in a unique population. J Mol Neurosci 2009; 37: 74-79.
87. Zhang J, Veasey S: Making sense of oxidative stress in obstructive sleep apnea: mediator or distractor? Front Neurol 2012; 3: 179.
88. Morrell MJ, Twigg G: Neural consequences of sleep disordered breathing: the role of intermittent hypoxia. Adv Exp Med Biol 2006; 588: 75-88.
89. Lim DC, Veasey SC: Neural Injury in sleep apnea. Curr Neurol Neurosci Rep 2010; 10: 47-52.
90. Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ: A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003; 26:893-901. (Pubitemid 39610638)
91. Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S: Melatonin fails to improve sleep or agitation in doubleblind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry 2009; 17: 166-169.
92. Serfaty M, Kennell-Webb S, Warner J, Blizard R, Raven P: Double-blind randomised placebo-controlled trial of low-dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry 2002; 17: 1120-1127. (Pubitemid 35469219)
93. Hartell NA, Suh YH: Peptide fragments of ?-amyloid precursor protein: effects on parallel fiber-Purkinje cell synaptic transmission in rat cerebellum. J Neurochem 2000; 74: 1112-1121. (Pubitemid 30104308)
94. Cantero JL, Hita-Yañez E, Moreno-Lopez B, Portillo F, Rubio A, Avila J: Tau protein role in sleep-wake cycle. J Alzheimers Dis 2010; 21: 411-421.
95. Wang JZ, Wang ZF: Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol Sin 2006; 27: 41-49.
96. Hernandez CM, Dineley KT: ?7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both? Curr Drug Targets 2012; 13: 613-622.
97. Spreng RN, Rosen HJ, Strother S, Chow TW, Diehl-Schmid J, Freedman M, Graff-Radford NR, Hodges JR, Lipton AM, Mendez MF, Morelli SA, Black SE, Miller BL, Levine B: Occupation attributes relate to location of atrophy in frontotemporal lobar degeneration. Neuropsychologia 2010; 48: 3634-3641.
98. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS: Environmental enrichment reduces A? levels and amyloid deposition in transgenic mice. Cell 2005; 120: 701-713. (Pubitemid 40343081)
99. Adlard PA, Perreau VM, Pop V, Cotman CW: Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 2005; 25: 4217-4221. (Pubitemid 40628765)
100. Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR: Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 2003; 62: 1220-1227. (Pubitemid 37494191)
101. Cotman CW, Berchtold NC: Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002; 25: 295-301. (Pubitemid 34667010)
102. Shi Y, Kirwan P, Smith J, Robinson HP, Livesey FJ: Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci 2012; 15: 477-486.